Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.

McHutchison, J G; Patel, K; Schiff, E R; Gitlin, N; Mur, R E; Everson, G T; Carithers, R L; Davis, G L; Marcellin, P; Shiffman, M L; Harvey, J; Albrecht, J K

McHutchison, J G; Patel, K; Schiff, E R; Gitlin, N; Mur, R E; Everson, G T; Carithers, R L; Davis, G L; Marcellin, P; Shiffman, M L; Harvey, J; Albrecht, J K.

Affiliation

McHutchison JG; Division of Gastroenterology, Gastrointestinal/Hepatology Research Program, Duke Clinical Research Institute, Durham, NC 27715, USA. mchut001@mc.duke.edu

Aliment Pharmacol Ther ; 27(5): 422-32, 2008 Mar 01.

Article de En | MEDLINE | ID: mdl-18081733

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Interféron alpha / Hépatite C chronique Type d'étude: Clinical_trials Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Aliment Pharmacol Ther Sujet du journal: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Année: 2008 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links